[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 7
2004 5
2005 7
2006 12
2007 5
2008 5
2009 4
2010 9
2011 10
2012 8
2013 11
2014 8
2015 13
2016 16
2017 3
2018 2
2019 3
2020 10
2021 11
2022 16
2023 8
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Lipid-based nanosystems: the next generation of cancer immune therapy.
Cheng Z, Fobian SF, Gurrieri E, Amin M, D'Agostino VG, Falahati M, Zalba S, Debets R, Garrido MJ, Saeed M, Seynhaeve ALB, Balcioglu HE, Ten Hagen TLM. Cheng Z, et al. Among authors: ten hagen tlm. J Hematol Oncol. 2024 Jul 19;17(1):53. doi: 10.1186/s13045-024-01574-1. J Hematol Oncol. 2024. PMID: 39030582 Free PMC article. Review.
Image-guided drug delivery in nanosystem-based cancer therapies.
Priester MI, Ten Hagen TLM. Priester MI, et al. Among authors: ten hagen tlm. Adv Drug Deliv Rev. 2023 Jan;192:114621. doi: 10.1016/j.addr.2022.114621. Epub 2022 Nov 17. Adv Drug Deliv Rev. 2023. PMID: 36402247 Free article. Review.
Stealth nanoparticles in oncology: Facing the PEG dilemma.
Zalba S, Ten Hagen TLM, Burgui C, Garrido MJ. Zalba S, et al. Among authors: ten hagen tlm. J Control Release. 2022 Nov;351:22-36. doi: 10.1016/j.jconrel.2022.09.002. Epub 2022 Sep 19. J Control Release. 2022. PMID: 36087801 Review.
CD81-guided heterologous EVs present heterogeneous interactions with breast cancer cells.
Gurrieri E, Carradori G, Roccuzzo M, Pancher M, Peroni D, Belli R, Trevisan C, Notarangelo M, Huang WQ, Carreira ASA, Quattrone A, Jenster G, Hagen TLMT, D'Agostino VG. Gurrieri E, et al. Among authors: hagen tlmt. J Biomed Sci. 2024 Oct 15;31(1):92. doi: 10.1186/s12929-024-01084-9. J Biomed Sci. 2024. PMID: 39402557 Free PMC article.
Core-shell inorganic NP@MOF nanostructures for targeted drug delivery and multimodal imaging-guided combination tumor treatment.
Khan S, Falahati M, Cho WC, Vahdani Y, Siddique R, Sharifi M, Jaragh-Alhadad LA, Haghighat S, Zhang X, Ten Hagen TLM, Bai Q. Khan S, et al. Among authors: ten hagen tlm. Adv Colloid Interface Sci. 2023 Nov;321:103007. doi: 10.1016/j.cis.2023.103007. Epub 2023 Sep 25. Adv Colloid Interface Sci. 2023. PMID: 37812992 Free article. Review.
Cell membrane modulation as adjuvant in cancer therapy.
Zalba S, Ten Hagen TL. Zalba S, et al. Among authors: ten hagen tl. Cancer Treat Rev. 2017 Jan;52:48-57. doi: 10.1016/j.ctrv.2016.10.008. Epub 2016 Nov 9. Cancer Treat Rev. 2017. PMID: 27889637 Free PMC article. Review.
The interaction mechanism of plasma iron transport protein transferrin with nanoparticles.
Khan S, Cho WC, Hussain A, Azimi S, Babadaei MMN, Bloukh SH, Edis Z, Saeed M, Ten Hagen TLM, Ahmadi H, Ale-Ebrahim M, Jaragh-Alhadad LA, Khan RH, Falahati M, Zhang X, Bai Q. Khan S, et al. Among authors: ten hagen tlm. Int J Biol Macromol. 2023 Jun 15;240:124441. doi: 10.1016/j.ijbiomac.2023.124441. Epub 2023 Apr 13. Int J Biol Macromol. 2023. PMID: 37060978 Review.
159 results